AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Rights to DynaGen's rapid antibody tests for tuberculosis and mycobacteria acquired. (Cambridge Biotech Corp.)

AIDS Weekly

| September 07, 1992 | COPYRIGHT 2009 NewsRX. (Hide copyright information)Copyright

Cambridge Biotech

Cambridge Biotech Corp. (CBC), Worcester, Massachusetts, and DynaGen Inc. announced the signing of a letter of intent under which CBC will develop and bring to market DynaGen's proprietary rapid test technologies for tuberculosis and other mycobacteria. CBC will acquire rights to certain of DynaGen's rapid test tuberculosis products. CBC plans to adapt the DynaGen technology to CBC's own patented diagnostic formats. Details of the agreement were not disclosed.

Related articles from newspapers, magazines, journals, and more
Risk factors for HIV infection in people attending clinics for sexually...
Magazine article from: British Medical Journal Rodrigues, Jeanette J. Mehendale, Sanjay M. Shepherd, Mary E. Divekar, Anand D. Gangakhedkar, Raman R. Quinn, Thomas C. Paranjape, Ramesh S. Risbud, Arun R. Brookmeyer, Ronald S. Gadkari, Deepak A. Gokhale, Manjusha R. Rompalo, Anne M. Deshpande, Shridhar G. Khalandkar, M.M. Mawar, Nita Bollinger, Robert C. July 29, 1995 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily